For instance, microRNA−7 (miR−7) has been identified as a diagnostic or prognostic biomarker in the colorectum, stomach, and liver cancers.28–30 The m6A modification of HDGF, meditated by METTL3, was an underlying prognostic and therapeutic target for gastric cancer.31 This evidence concerns the gene METTL3 and liver cancer.